Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease.
Beck IT, Champion MC, Lemire S, Thomson AB, Anvari M, Armstrong D, Bailey RJ, Barkun AN, Boivin M, Bursey RF, Chaun H, Chiba N, Cockeram AW, Connon JJ, Da Costa LR, Faloon TR, Fedorak RN, Gillies RR, Goeree R, Hunt RH, Inculet RI, Klein A, Leddin DJ, Love JR, Worobetz LJ, et al. Beck IT, et al. Among authors: fedorak rn. Can J Gastroenterol. 1997 Sep;11 Suppl B:7B-20B. Can J Gastroenterol. 1997. PMID: 9347173 Review.
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Wurzer H, Rodrigo L, Stamler D, Archambault A, Rokkas T, Skandalis N, Fedorak R, Bazzoli F, Hentschel E, Mora P, Archimandritis A, Megraud F. Wurzer H, et al. Aliment Pharmacol Ther. 1997 Oct;11(5):943-52. doi: 10.1046/j.1365-2036.1997.00223.x. Aliment Pharmacol Ther. 1997. PMID: 9354205 Free article. Clinical Trial.
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort.
Waugh AW, Garg S, Matic K, Gramlich L, Wong C, Sadowski DC, Millan M, Bailey R, Todoruk D, Cherry R, Teshima CW, Dieleman L, Fedorak RN. Waugh AW, et al. Among authors: fedorak rn. Aliment Pharmacol Ther. 2010 Nov;32(9):1129-34. doi: 10.1111/j.1365-2036.2010.04446.x. Epub 2010 Aug 30. Aliment Pharmacol Ther. 2010. PMID: 20807218 Free article.
A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR, Martin F, Bailey RJ, Fedorak RN, Poleski M, Dallaire C, Rossman R, Saibil F, Lariviere L. Sutherland LR, et al. Among authors: fedorak rn. Gastroenterology. 1997 Apr;112(4):1069-77. doi: 10.1016/s0016-5085(97)70117-3. Gastroenterology. 1997. PMID: 9097988 Clinical Trial.
283 results